124 related articles for article (PubMed ID: 36404720)
1. Long Noncoding RNA HOXA-AS2 Facilitates Prostate Cancer Progression by Inhibiting miR-885-5p to Upregulate KDM5B.
Yang Z; Zhang F; Cai K; Xu J
Kidney Blood Press Res; 2023; 48(1):45-55. PubMed ID: 36404720
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
Xiao S; Song B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.
Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C
Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells.
Wang Y; Zhang R; Cheng G; Xu R; Han X
Cell Cycle; 2018; 17(13):1637-1648. PubMed ID: 30081707
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p.
Liu Y; Lin X; Zhou S; Zhang P; Shao G; Yang Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064819
[No Abstract] [Full Text] [Related]
7. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
9. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
10. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
11. HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.
Sun J; Wang L
BMC Cancer; 2022 Apr; 22(1):366. PubMed ID: 35387643
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA
Gao K; Lv A; Zhang Q; Li Y; Yue Z; Xu S
Allergol Immunopathol (Madr); 2023; 51(2):36-44. PubMed ID: 36916086
[TBL] [Abstract][Full Text] [Related]
13. SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop.
Li H; Xue Y; Ma J; Shao L; Wang D; Zheng J; Liu X; Yang C; He Q; Ruan X; Li Z; Liu Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):59. PubMed ID: 30728054
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
Li Z
BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
[TBL] [Abstract][Full Text] [Related]
16. HOXA-AS2 contributes to regulatory T cell proliferation and immune tolerance in glioma through the miR-302a/KDM2A/JAG1 axis.
Zhong C; Tao B; Li X; Xiang W; Peng L; Peng T; Chen L; Xia X; You J; Yang X
Cell Death Dis; 2022 Feb; 13(2):160. PubMed ID: 35181676
[TBL] [Abstract][Full Text] [Related]
17. miR424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway.
Zhou Y; An Q; Guo RX; Qiao YH; Li LX; Zhang XY; Zhao XL
Life Sci; 2017 Feb; 171():9-15. PubMed ID: 28082020
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis.
Chen R; He P
J Pharm Pharmacol; 2021 Sep; 73(10):1387-1396. PubMed ID: 34240204
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HOXA-AS2 mediates microRNA-106b-5p to repress sepsis-engendered acute kidney injury.
Wu H; Wang J; Ma Z
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22453. PubMed ID: 32048402
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
